Clinical Trials in Denver

Showing 2981-3000 of 15,604 trials

Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal Melanoma

NCT04935229

This study is an open-label, phase 1/1b study of the pressure-enabled hepatic artery infusion of SD-101, a TLR 9 agonist, alone or in combination with intravenous checkpoint blockade in adults with metastatic uveal melanoma.

Metastatic Uveal Melanoma in the Liver

TriSalus Life Sciences, Inc.67 participantsStarted Aug 2021

Los Angeles, California, United States • Stanford, California, United States • Denver, Colorado, United States +7 more locations

Active Not RecruitingPhase 2/3< 1 mile

Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

NCT03898479

The overall objectives of the study are to evaluate long-term safety of CTP-543 and to assess long-term effects of CTP-543 on treating hair loss in adult patients with chronic, moderate to severe alopecia areata.

Alopecia Areata

Sun Pharmaceutical Industries, Inc.1,000 participantsStarted Apr 2019

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +88 more locations

Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal Melanoma

Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

Find Trials by Condition in Denver

Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies

Safety and Proof-of-Concept (POC) Study With AMT-130 in Adults With Early Manifest Huntington's Disease

Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer

GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease

Hearing Impairment, Strategies and Outcomes in VA Emergency Departments

A Study of ZW171 in Participants With Advanced or Metastatic Mesothelin-expressing Cancers

A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

Study of Fordadistrogene Movaparvovec in Early Stage Duchenne Muscular Dystrophy

Study of Daxdilimab (HZN-7734) in Participants With Moderate-to-Severe Primary Discoid Lupus Erythematosus

Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants With SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)

Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study

Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder (CURB-2)

CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW Populations

First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)

Azacitidine Combined With Pembrolizumab and Epacadostat in Subjects With Advanced Solid Tumors (ECHO-206)

Nonhealing Diabetic Foot Ulcers Treated With Standard of Care (SOC) Alone or Standard of Care and Amnion-Intermediate-Chorion (AIC)

Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection